Company intelligence / Profile preview

BioScience Strategy IQ

California, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

iQ Biosciences provides high-quality biospecimens, in vitro assays, bioconjugation expertise, and dependable immune cell products to support pharmaceutical, biotechnology, academic, and diagnostic industry clients in their preclinical discovery efforts. They do not have their own clinical pipeline but enable client programs through contract research services.

Modalities: Small moleculeBiologicCell therapyAntibody
Industry: Drug Discovery Services

Beyond the preview

Go deeper on BioScience Strategy IQ.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioScience Strategy IQ.

Explore the full profile